These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 18852294

  • 1. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells.
    Meiron M, Zohar Y, Anunu R, Wildbaum G, Karin N.
    J Exp Med; 2008 Oct 27; 205(11):2643-55. PubMed ID: 18852294
    [Abstract] [Full Text] [Related]

  • 2. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
    Jee Y, Piao WH, Liu R, Bai XF, Rhodes S, Rodebaugh R, Campagnolo DI, Shi FD, Vollmer TL.
    Clin Immunol; 2007 Oct 27; 125(1):34-42. PubMed ID: 17632037
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B, Bommhardt UH.
    J Immunol; 2009 Nov 15; 183(10):6124-34. PubMed ID: 19841181
    [Abstract] [Full Text] [Related]

  • 4. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.
    Piao WH, Jee YH, Liu RL, Coons SW, Kala M, Collins M, Young DA, Campagnolo DI, Vollmer TL, Bai XF, La Cava A, Shi FD.
    Scand J Immunol; 2008 Jan 15; 67(1):37-46. PubMed ID: 18052963
    [Abstract] [Full Text] [Related]

  • 5. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portolés P.
    Int Immunol; 2008 Apr 15; 20(4):577-89. PubMed ID: 18310064
    [Abstract] [Full Text] [Related]

  • 6. Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells.
    Sonobe Y, Li H, Jin S, Kishida S, Kadomatsu K, Takeuchi H, Mizuno T, Suzumura A.
    J Immunol; 2012 Mar 15; 188(6):2602-11. PubMed ID: 22323540
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.
    Fernandez-Martin A, Gonzalez-Rey E, Chorny A, Ganea D, Delgado M.
    Eur J Immunol; 2006 Feb 15; 36(2):318-26. PubMed ID: 16402407
    [Abstract] [Full Text] [Related]

  • 8. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
    Chen X, Fang L, Song S, Guo TB, Liu A, Zhang JZ.
    J Immunol; 2009 Nov 15; 183(10):6135-44. PubMed ID: 19841165
    [Abstract] [Full Text] [Related]

  • 9. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
    Kuwabara T, Ishikawa F, Yasuda T, Aritomi K, Nakano H, Tanaka Y, Okada Y, Lipp M, Kakiuchi T.
    J Immunol; 2009 Aug 15; 183(4):2513-21. PubMed ID: 19625643
    [Abstract] [Full Text] [Related]

  • 10. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.
    Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J.
    J Immunol; 2009 May 15; 182(10):5994-6002. PubMed ID: 19414750
    [Abstract] [Full Text] [Related]

  • 11. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R.
    Eur J Immunol; 2009 Jun 15; 39(6):1671-81. PubMed ID: 19499521
    [Abstract] [Full Text] [Related]

  • 12. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
    Lange C, Doster H, Steinbach K, Kalbacher H, Scholl M, Melms A, Bischof F.
    Brain Behav Immun; 2009 Aug 15; 23(6):861-7. PubMed ID: 19362139
    [Abstract] [Full Text] [Related]

  • 13. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T, Hirata S, Fukushima S, Matsunaga Y, Ito T, Uchino M, Nishimura Y, Senju S.
    J Immunol; 2010 Nov 01; 185(9):5259-67. PubMed ID: 20921531
    [Abstract] [Full Text] [Related]

  • 14. Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3(+) regulatory T cells.
    Sashinami H, Asano K, Yoshimura S, Mori F, Wakabayashi K, Nakane A.
    Life Sci; 2012 Dec 17; 91(25-26):1263-9. PubMed ID: 23069584
    [Abstract] [Full Text] [Related]

  • 15. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
    Gyülvészi G, Haak S, Becher B.
    Eur J Immunol; 2009 Jul 17; 39(7):1864-9. PubMed ID: 19544494
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.